Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Farah Mazahreh"'
Publikováno v:
Clinics and Practice, Vol 11, Iss 3, Pp 455-458 (2021)
A 41-year-old woman with no significant past medical history presented to the hospital with complaints of nausea, vomiting, and generalized weakness over two weeks. The patient did not seek medical attention as she assumed that her symptoms willwould
Externí odkaz:
https://doaj.org/article/d08d56faad8a43b7a3554721b90a5a34
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:332-334
Autor:
Farah Mazahreh, Liyan Mazahreh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy, Fenghuang Zhan, Frits Van Rhee, Samer AI Al Hadidi
Publikováno v:
Blood Advances.
The use of bispecific antibodies (BsAbs) in the treatment of relapsed/refractory multiple myeloma (MM) is showing early promising overall response rates in heavily pre-treated patients. Infectious complications related to the use of BsAbs are not wel
Publikováno v:
Cancer Research. 83:4385-4385
Background: Classic therapeutic (RX) oncology principles demand radiographic response or durable stable disease as surrogates of overall survival (OS) prolongation, the ultimate metric of Rx benefit. Progressive disease (PD), however, is an undispute
Publikováno v:
Cureus
Venous thromboembolism (VTE) is a common condition whose pathophysiology is explained by Virchow's triad with stasis, hypercoagulability, and endothelial injury. Direct oral anticoagulants (DOACs) showed non-inferiority when compared with conventiona
Publikováno v:
Cancer Research. 82:1292-1292
Metastatic cancer (C) is incurable save for solitary/oligometastatic presentations after curative M, a standard care agnostic to tumor (Tu) biology. Despite complete resection, Cu is achieved only in a minority. Importantly, mechanistic understanding